|
|
|
Corporate Profile: CureDM
| Summary: |
CureDM is focused on the research of development of therapeutics approaches to restore, maintain and protect new insulin-producing islet structures in patients with diabetes.
|
| Address (HQ): |
1201 N. Market Street
Suite 701
Wilmington, DE 19801
|
| Phone #'s (HQ): |
| Main |
(302) 288-0620 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
